The Role of Family, Microsocial and Medical History in The Shaping of Trajectories of Complex Opioid and Cannabis Addiction: Results of Machine Learning Modeling
https://doi.org/10.52667/2712-9179-2023-3-2-120-133
Abstract
Introduction: The widespread misuse of opioids and cannabis is a notable global public health concern. The substantial public health concern due to the misuse of opioids and cannabis, individually and concurrently, is associated with vast societal implications. Identification of risk factors for developing misuse of these substances is of utmost importance. This study aims at developing a machine learning-based model to classify groups of opioid or cannabis dependents using family, microsocial, and medical history variables, and to identify the most significant variables associated with each group.
Methods: This naturalistic observational non-interventional study enrolled adult patients diagnosed with opioid use disorder, cannabis use disorder, or a combination of both. Machine learning models, including Stacking, Logistic Regression, Gradient Boosting, k-Nearest Neighbors (kNN), Naive Bayes, Support Vector Machines (SVM), Random Forest, and Decision Tree, were used to classify patients and predict their risk factors based on various personal history variables.
Results: The patient groups showed significant differences in their working fields, marital status before and after the formation of drug addiction, substance misuse in relatives, family type, parent-child relationships, and birth order. They also differed significantly in fleeing from home and personality types. Machine learning models provided high classification accuracy across all substance dependence groups, particularly for the cannabis group (>90% accuracy). Significant differences were found among the complex misuse group, where individuals faced severe psychosocial issues originating from the familial environment, such as a history of fleeing home, coming from a single-parent family, and dominant parent-child relationships.
Discussion: The methods used in this study provided robust and reliable assessments of the models' predictive performances. The results pointed to significant differences in familial and developmental factors between the three dependence groups. The complex dependence group showed more severe psychosocial issues originating from the family environment. This group also revealed a specific sequence of life events and conditions predictive of complex dependence. These findings highlight the importance of interventions that address risk factors across various life stages and domains. Conclusion: Early identification of high-risk individuals and understanding the risk factors can inform the development of effective interventions at both individual and societal levels, ultimately aiming at mitigating dependence risks and improving overall well-being. Further research with longitudinal designs and diverse populations are needed to increase our understanding of trajectory of addiction formation in order to deliver effective interventions for individuals at risk.
About the Authors
T. SyunyakovUzbekistan
Timur Syunyakov
Tashkent
443099, Samara
I. Khayredinova
Uzbekistan
Inara Khayredinova
Tashkent
Z. Ashurov
Uzbekistan
Zarifjon Ashurov
Tashkent
References
1. Faller, J.; Le, LK-D.; Chatterton, M.L.; Perez, J.K.; Chiotelis, O.; Tran, H.N.Q. et al. A systematic review of economic evaluations for opioid misuse, cannabis and illicit drug use prevention. BJPsych Open. 2023; 9(5). doi: 10.1192/bjo.2023.515.
2. Lewer, D.; Freer, J.; King, E.; Larney, S.; Degenhardt, L.; Tweed, E.J. et al. Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis. Addiction. 2020; 115(6): 1011-1023. doi: 10.1111/add.14892.
3. Aldridge, R.W.; Story, A.; Hwang, S.W.; Nordentoft, M.; Luchenski, S.A.; Hartwell, G. et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. The Lancet. 2018; 391(10117) :241-50.
4. Lewer, D.; Tweed, E.J.; Aldridge, R.W.; Morley, K.I. Causes of hospital admission and mortality among 6683 people who use heroin: A cohort study comparing relative and absolute risks. Drug and alcohol dependence. 2019; 204: 107525.
5. Reisfield, G.M. Medical cannabis and chronic opioid therapy. J Pain Palliat Care Pharmacother. 2010; 24(4): 356-61. doi: 10.3109/15360288.2010.519431.
6. Williams, A.R. Cannabis as a Gateway Drug for Opioid Use Disorder. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics. 2020; 48(2): 268-74. doi: 10.1177/1073110520935338.
7. Lake, S.; Walsh, Z.; Kerr, T.; Cooper, Z.D.; Buxton, J.; Wood, E. et al. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLoS medicine. 2019; 16(11): e1002967. doi: 10.1371/journal.pmed.1002967.
8. Liang, D.; Wallace, M.S.; Shi, Y. Medical and non-medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching. Drug Alcohol Rev. 2019; 38(6): 597-605. doi: 10.1111/dar.12964.
9. Rogers, A.H.; Bakhshaie, J.; Buckner, J.D.; Orr, M.F.; Paulus, D.J.; Ditre, J.W. et al. Opioid and Cannabis Co-Use among Adults With Chronic Pain: Relations to Substance Misuse, Mental Health, and Pain Experience. J Addict Med. 2019; 13(4): 287-294. doi: 10.1097/ADM.0000000000000493.
10. Hudgins, J.D.; Porter, J.J.; Monuteaux, M.C.; Bourgeois, F.T. Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study. PLoS medicine. 2019; 16(11): e1002922. doi: 10.1371/journal.pmed.1002922.
11. Reback, J.; McKinney, W.; Van Den Bossche, J.; Augspurger, T.; Cloud, P.; Klein, A. et al. pandas-dev/pandas: Pandas 1.0. 5. Zenodo. 2020.
12. McKinney, W. Data structures for statistical computing in python. Proceedings of the 9th Python in Science Conference: Austin, TX; 2010, 51-56.
13. Virtanen, P.; Gommers, R.; Oliphant, T.E.; Haberland, M.; Reddy, T.; Cournapeau, D. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nature methods. 2020; 17(3): 261-272.
14. Pedregosa, F.; Varoquaux, G.; Gramfort, A.; Michel, V.; Thirion, B.; Grisel, O. et al. Scikit-learn: Machine learning in Python. the Journal of machine Learning research. 2011; 12: 2825-30.
15. Lundberg, S.M.; Lee, S-I. A unified approach to interpreting model predictions. Advances in neural information processing systems. 2017, 4765-4774.
16. Merikangas, K.R.; Dierker, L.; Fenton, B. Familial factors and substance abuse: Implications for prevention. Drug abuse prevention through family interventions. 1998, 12-41.
17. Whitesell, M.; Bachand, A.; Peel, J.; Brown, M. Familial, Social, and Individual Factors Contributing to Risk for Adolescent Substance Use. Journal of Addiction. 2013; 2013: 1-9. doi: 10.1155/2013/579310.
18. Konkolÿ Thege, B.; Horwood, L.; Slater, L.; Tan, M.C.; Hodgins, D.C.; Wild, T.C. Relationship between interpersonal trauma exposure and addictive behaviors: a systematic review. BMC psychiatry. 2017; 17: 1-17.
Review
For citations:
Syunyakov T., Khayredinova I., Ashurov Z. The Role of Family, Microsocial and Medical History in The Shaping of Trajectories of Complex Opioid and Cannabis Addiction: Results of Machine Learning Modeling. Personalized Psychiatry and Neurology. 2023;3(2):120-133. https://doi.org/10.52667/2712-9179-2023-3-2-120-133